In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...

The popular weight-loss and diabetes drugs could play a significant role not only in disease prevention, but possibly in ...

When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Sally Love has always enjoyed a drink - but, like many, it was during the Covid pandemic that her alcohol intake began to ...

University of Pennsylvania and Syracuse University scientists have discovered that a hindbrain-derived peptide, octadecaneuropeptide (ODN), can suppress appetite and improve glucose regulation without ...

A recent study revealed that individuals taking weight-loss drugs, including renowned GLP-1s, may significantly regain weight ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

A quarter-size device that tracks the rise and fall of sugar in your blood is the latest source of hope — and hype — in the growing buzz around wearable health technology.Video above: Weight-loss ...

New research reveals weight is swiftly regained after discontinuing anti-obesity medications like Ozempic, despite their ...

Novo Nordisk Pakistan hosted “Unordinary Partnerships to Shape a Healthier Tomorrow” that brought together healthcare ...